A Phase 2 Prospective Trial of Capecitabine Plus Oxaliplatin as First-Line Therapy for Advanced Gall Bladder Cancers

Volume 26, Issue 10, October 2025, Pages 3761-3767

Vivek Goti; Mohd Waseem Raza; Archana Singh; Shambhu N Prasad

• View Article
• PDF 435.28 K

The Effectiveness and Adverse Events of Eribulin Monotherapy in Indonesian Metastatic Breast Cancer (MBC) Patients

Volume 26, Issue 5, May 2025, Pages 1773-1780

Putu Anda Tusta Adiputra; Kristina Maria Siswiandari; Dhian Hangesti; Nur Qodir; Walta Gautama; Dedy Hermansyah

• View Article
• PDF 610.17 K

ERCC1 Expression in Metastatic Triple Negative Breast Cancer Patients Treated with Platinum-Based Chemotherapy

Volume 18, Issue 2, February 2017, Pages 507-513

Mohamed Ali El Baiomy; Wagdi F El Kashef

• View Article
• PDF 409.13 K

Individualized Chemotherapy for Metastatic Gastric Cancer: Retrospective Data from a University Hospital in Brazil

Volume 16, Issue 13, December 2015, Pages 5289-5296

• View Article
• PDF 1.09 M

Metastatic Colorectal Cancer Treatment and Survival: the Experience of Major Public Hospitals in South Australia Over Three Decades

Volume 16, Issue 14, December 2015, Pages 5923-5931

• View Article
• PDF 650.4 K

Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology Study

Volume 16, Issue 9, September 2015, Pages 4127-4131

• View Article
• PDF 377.94 K

Prognostic Factors on Overall Survival of Newly Diagnosed Metastatic Nasopharyngeal Carcinoma

Volume 15, Issue 7, July 2014, Pages 3169-3173

• View Article
• PDF 373.32 K

Metastatic Lymphadenopathy in Kashmir Valley: A Clinicopathological Study

Volume 15, Issue 1, January 2014, Pages 419-422

• View Article
• PDF 307.97 K